Dermata Therapeutics, Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Dermata Therapeutics filed Form 8-K on 2026-08-05 disclosing other events (Item 8.01). The actual substantive content of the event disclosure is not provided in the filing metadata — only the structural EDGAR submission information is visible. No counterparties, dollar amounts, share counts, dates of material changes, or business developments are specified in the available text.
Why this rating
Filing metadata only; no material event described. Impossible to assess business impact without disclosure content.
Extracted items
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.